Thursday, March 28, 2013

Texas-Based Savara Pharmaceuticals Preps For Phase 2 Study of Inhaled Antibiotic For CF Patients

Texas-Based Savara Pharmaceuticals Preps For Phase 2 Study of Inhaled Antibiotic For CF Patients

http://bionews-tx.com/news/2013/03/28/texas-based-savara-pharmaceuticals-preps-for-phase-2-study-of-inhaled-antibiotic-for-cf-patients/
at
Labels: , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)